Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Inhibition of telomerase limits the growth of human cancer cells

Article Abstract:

Drugs that inhibit telomerase might kill tumor cells. Telomerase is an enzyme that maintains telomeres, which lead to the immortalization of the cell. Researchers created a mutant enzyme that caused the death of tumor cells in vitro. Telomerase has a structure similar to reverse transcriptases.

Author: Weinberg, Robert A., Hahn, William C., Knoll, Joan H.M., Brooks, Mary W., Stewart, Sheila A., Beijersbergen, Roderick L., Meyerson, Matthew, York, Shoshana G., Eaton, Elinor, Kurachi, Akiko
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 1999
Research, Growth, Cancer cells, Telomerase

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Inflammatory pathways and cardiac repair: the affliction of infarction

Article Abstract:

Inhibiting plasminogen activator and matrix metalloproteinases might prevent some of the complications of heart attack. Many molecular and cellular changes occur in heart tissue that can lead to cardiac rupture, arrhythmias, aneurysms, sudden cardiac death and heart failure.

Author: Chien, Kenneth R., Knowlton, Kirk U.
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 1999
Physiological aspects, Infarction

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

Article Abstract:

In a mouse model, plasminogen activator inhibitor-1 prevented cardiac rupture after a heart attack, as did the matrix metalloproteinase-inhibitor TIMP-1. Cardiac rupture is a serious complication of heart attack, accounting for up to 31% of all in-hospital deaths.

Author: Baker, A., Heymans, S., Luttun, A., Nuyens, D., Theilmeier, G., Creemers, E., Moons, L., Dyspersin, G.D., Cleutjens, J.P.M., Shipley, M., Angellilo, A., Levi, M., Nube, O., Keshet, E., Lupu, F., Herbert, J.-M., Smits, J.F.M., Shapiro, S.D., Baes, M., Borgers, M., Collen, D., Daemen, M.J.A.P., Carmeliet, P.
Publisher: Nature America, Inc.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 1999
Complications and side effects

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Enzyme inhibitors, Heart attack, Heart
Similar abstracts:
  • Abstracts: Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells
  • Abstracts: Dietary advice in systemic sclerosis: the dangers of a high fibre diet. Chronic fatigue, arthralgia, and malaise
  • Abstracts: Keeping Abreast of the Changes in the Treatment of Hypertension. Treatment of Ganglion Cysts of the Wrist by Aspiration
  • Abstracts: Concentrations of tocopherols and carotenoids in maternal and cord blood plasma. Plasma kinetics in man of epicatechin from black chocolate
  • Abstracts: Reappraising the value of urine leukocyte esterase testing in the age of nucleic acid amplification. The acceptability of oral fluid testing for HIV antibodies: a pilot study in gay bars in a predominantly rural state
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.